Hologic closes Suros acquisition:
This article was originally published in Clinica
Bedford, Massachusetts-based mammography systems specialist Hologic has completed its acquisition of Suros Surgical Systems. The company had agreed in April to pay $240m cash-and-stock for the breast biopsy and tissue removal systems developer, based in Indianapolis, Indiana, as well as additional earn-outs based on Suros' product sales over the next two years (see Clinica No 1203, p 17).
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.